Related Experiment Video

Updated: May 11, 2026

Patient-derived Orthotopic Xenograft Models for Human Urothelial Cell Carcinoma and Colorectal Cancer Tumor Growth and Spontaneous Metastasis
09:28

Patient-derived Orthotopic Xenograft Models for Human Urothelial Cell Carcinoma and Colorectal Cancer Tumor Growth and Spontaneous Metastasis

Published on: May 12, 2019

Advanced urothelial carcinoma: moving the field forward

Matthew I Milowsky1

  • 1Department of Medicine, Division of Hematology and Medical Oncology, University of North Carolina at Chapel Hill Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, USA.

Oncology (Williston Park, N.Y.)
|May 22, 2013
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Technical Modification of the Terminal Ureter During Total Transperitoneal Laparoscopic Nephroureterectomy for Upper Urinary Tract Urothelial Carcinoma
06:39

Technical Modification of the Terminal Ureter During Total Transperitoneal Laparoscopic Nephroureterectomy for Upper Urinary Tract Urothelial Carcinoma

Published on: November 22, 2019

Related Experiment Videos

Last Updated: May 11, 2026

Patient-derived Orthotopic Xenograft Models for Human Urothelial Cell Carcinoma and Colorectal Cancer Tumor Growth and Spontaneous Metastasis
09:28

Patient-derived Orthotopic Xenograft Models for Human Urothelial Cell Carcinoma and Colorectal Cancer Tumor Growth and Spontaneous Metastasis

Published on: May 12, 2019

Technical Modification of the Terminal Ureter During Total Transperitoneal Laparoscopic Nephroureterectomy for Upper Urinary Tract Urothelial Carcinoma
06:39

Technical Modification of the Terminal Ureter During Total Transperitoneal Laparoscopic Nephroureterectomy for Upper Urinary Tract Urothelial Carcinoma

Published on: November 22, 2019

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

Articles linked to this work by shared authors, journal, and citation graph.

Online support needs and preferences for survivors of testicular cancer: a qualitative descriptive study.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2026

Pembrolizumab in Combination With Gemcitabine and Concurrent Hypofractionated Radiation Therapy as Bladder-sparing Treatment for Muscle-invasive Urothelial Cancer of the Bladder: A Multicenter Phase 2 Trial.

European urology·2026

Repeatability of Semi-Quantitative and Volumetric Features from Artificial-Intelligence-Guided Lesion Segmentation on 18F-DCFPyL PSMA-PET/CT Images: Results from a Test-Retest Cohort.

Tomography (Ann Arbor, Mich.)·2026

A small-molecule inverse agonist of PPARγ for advanced solid tumors: a phase 1 trial.

Nature medicine·2026

Current perspective on the impact of endogenous retroviruses in clear cell renal cell carcinoma.

Kidney cancer journal : official journal of the Kidney Cancer Association·2026

APOBEC3 promotes squamous differentiation via IL-1A/AP-1 signaling.

Nature communications·2025

Advancing Multidisciplinary Care and Health Equity in Metastatic Breast Cancer.

Oncology (Williston Park, N.Y.)·2026

Homologous Recombination and Mismatch Repair Assessment in Men With Advanced Prostate Cancer: A Cross-Sectional Study From a Center in Mexico City.

Oncology (Williston Park, N.Y.)·2026

Access to Care and Drug Prices: Recent Department of Health and Human Services Guidance.

Oncology (Williston Park, N.Y.)·2026

Clinical Outcomes of Acute Pancreatitis in Patients With Multiple Myeloma.

Oncology (Williston Park, N.Y.)·2026

Primary Malignant Melanoma of the Colon: A Rare and Challenging Diagnosis.

Oncology (Williston Park, N.Y.)·2026

Emerging T-Cell Engagers and Novel Immunotargets in Multiple Myeloma.

Oncology (Williston Park, N.Y.)·2026

An Intravesical Akkermansia muciniphila-Based Chemo-Immunotherapeutic Platform for Bladder Cancer.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026

ETS1-EGR2 facilitates renal cell carcinoma progression by activating NOTCH signalling.

Clinical and translational medicine·2026

CLIC3 promotes lung cancer cell proliferation by regulating intracellular chloride and ROS levels.

Gene·2026

Aging's Competing Paradigms: Another Decade of Investigation into Damage-Driven versus Programmed Theories.

Ageing research reviews·2026

Imbalanced p53-RB signaling triggers cGAS-STING-mediated immune activation in early oral cancer development.

Oncogene·2026

Research advances in the recurrence patterns of glioblastoma.

Biochimica et biophysica acta. Reviews on cancer·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us